WallStreetZenWallStreetZen

NASDAQ: ANEB
Anebulo Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Anebulo Pharmaceuticals revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, ANEB annual revenue was $0.0, with N/A growth year-over-year.

ANEB revenue history

Current Revenue
$0.0
Current Earnings
-$7.7M
Current Profit Margin
0%

Be the first to know when ANEB announces revenue.

ANEB Revenue History By Year

ANEB Yearly RevenueANEB RevenueANEB ChangeANEB Revenue Growth
2024-06-30$0.00N/AN/A
2023-06-30$0.00N/AN/A
2022-06-30$0.00N/AN/A
2021-06-30$0.00N/AN/A

1 of 1

Anebulo Pharmaceuticals Revenue FAQ

What was ANEB's revenue last quarter?

On Invalid Date, Anebulo Pharmaceuticals (NASDAQ: ANEB) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Anebulo Pharmaceuticals's revenue was $0.00.

What was Anebulo Pharmaceuticals's revenue in 2024?

Anebulo Pharmaceuticals's annual revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.

How much does Anebulo Pharmaceuticals make in a day?

Based on Anebulo Pharmaceuticals annual revenue for the past three years, ANEB makes an average of $0.00 per day.

What was Anebulo Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Anebulo Pharmaceuticals's revenue has grown null year over year. Anebulo Pharmaceuticals's revenue in the past year totaled $0.00.

How much does Anebulo Pharmaceuticals make in a year?

Anebulo Pharmaceuticals's revenue by year for the past three years is:
  • Anebulo Pharmaceuticals's revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.
  • Anebulo Pharmaceuticals's annual revenue for Jun 30, 2023 was $0.00, a N/A decrease from 2022.
  • Anebulo Pharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.